Brief Description of the organization and summary of experiences relevant to the project
The International Prevention Research Institute (IPRI), established in 2009, is a foundation of highly experienced epidemiologists, biostatisticians and applied mathematicians in the field of diseases prevention. IPRI is a new concept in biomedical research combining a through, high level, academic approach coupled with a practical focus on providing clear information about evidence-based clinical, epidemiological and prevention strategies. It serves as an independent authoritative source of advice on critical risk issues and as a high-level training centre in all aspects of Prevention research.
IPRI has unparalleled experience in epidemiological research and macro health planning with a record of delivering real health and economic value to a range of public and private sources including governments, universities, research institutes, non-governmental organisations and large multi-national concerns.
The vast majority of senior researchers at IPRI hold academic positions at different Universities around the world. IPRI participates with Strathclyde University of Glasgow (UK) in the ” University of Strathclyde Institute of Global Public Health at iPRI” in Lyon (France).
IPRI has been and is member of several international collaborative research projects, and in particular of the following EU-funded projects: EUROSUN (coordinating centre), OncoTrack, ITFom, ASSET, as well as to the EU-funded BBMRI Research Infrastructure and the ECNIS Network of Excellence.
|
Alberto d'Onofrio (MAN)
Alberto d'Onofrio is a Research Director at the International Prevention Research Institute. He was born in Naples, Italy, on May 20 1967, and graduated in Electrical and Control Engineering at the University of Pisa, Italy and subsequently obtained a PhD in Medical Computer Sciences from the University of Rome-'La Sapienza', Italy. Alberto d'Onofrio's main activities are on mathematical epidemiology of infectious diseases, statistical epidemiology of cancer and cancer systems biomedicine. Broadly speaking, he is interested in the effects of nonlinearity and randomness in biological phenomena, from microscopic to population level. Until now he has published 96 papers (mainly as corresponding author) in ISI-indexed international journals and peer refereed books. He has edited 5 collective books for international publishing houses, including the first book ever published on Behavioral Epidemiology. His H-index is 19 (oct 2013), his G index is 25. He has also contributed and is contributing to various international projects on: preparadness to pandemic infections (EU ASSET), computational biology (EU ACGT; EU p-medicine), geographic epidemiology of cancer (WHO Atlas for Cancer Mortality in Europe 1993-1997), and cancer prevention (EU Code Against the Cancer 2003 - Demographic Committee). He is the chair scientific organizer of International Conferences “Mathematical and Computational Epidemiology of Infectious Diseases: the interplay between modelling and publich health”at the Centre Ettore Majorana, Erice, Italy, from 30 Aug 2015 – 5 Sept 2015, as well as of other conferences and minysimposia in the field of mathematical biology. He has been at the European Institute of Oncology in Milan from 2000 to 2013 starting as Professor Peter Boyle's postdoc fellow and ending there as Principal Investigator in Systems Biomedicine. Detailed CV can be found here Five selected publications can be found here
Mathieu Boniol (MAN)
Mathieu Boniol is a Vice-President, Biostatistics at the International Prevention Research Institute. He was born in Nimes, France, and graduated in Biomathematics and Public Health at the University Lyon 1, France and subsequently obtained a PhD in epidemiology from the Université de Bourgogne, Dijon. Mathieu Boniol's main activities are on epidemiology of melanoma. He has also contributed to various international collaborative projects involving computation of attributable fraction and to various meta-analyses (melanoma risk, artificial light and skin cancer, vitamin D and cancer). He is the coordinator of the EU-funded project EUROSUN. He is a member of the International Task Force on Skin Cancer Screening and Prevention that evaluates the national skin cancer screening in Germany. As of the 12th of December 2011, he has been unanimously elected President of Euroskin (the European Society of Skin Cancer Prevention). In 2013 he was appointed as Professor at Strathclyde University.
Guillaime Noyel (MAN) |
